References
- Maymone MBC, Neamah HH, Wirya SA. The impact of skin hyperpigmentation and hyperchromia on quality of life: a cross-sectional study. J Am Acad Dermatol. 2017;77(4):775–778. doi:10.1016/j.jaad.2017.05.009
- Lindgren AL, Austin AH, Welsh KM. The use of tranexamic acid to prevent and treat post-inflammatory hyperpigmentation. J Drugs Dermatol. 2021;20(3):344–345. doi:10.36849/JDD.5622
- Shenoy A, Madan R. Post-inflammatory hyperpigmentation: a review of treatment strategies. J Drugs Dermatol. 2020;19(8):763–768. doi:10.36849/JDD.2020.4887
- Bae YS, Rettig S, Weiss E, Bernstein L, Geronemus R. Treatment of post‐inflammatory hyperpigmentation in patients with darker skin types using a low energy 1927 nm non‐ablative fractional laser: a retrospective photographic review analysis. Lasers Surg Med. 2020;52(1):7–12. doi:10.1002/lsm.23173
- Park JH, Kim JI, Kim WS. Treatment of persistent facial postinflammatory hyperpigmentation with novel pulse-in-pulse mode intense pulsed light. Dermatol Surg. 2016;42(2):218–224. doi:10.1097/DSS.0000000000000627
- Agbai O, Hamzavi I, Jagdeo J. Laser treatments for postinflammatory hyperpigmentation: a systematic review. JAMA Dermatol. 2017;153(2):199–206. doi:10.1001/jamadermatol.2016.4399
- Hu S, Yang CS, Chang SL, et al. Efficacy and safety of the picosecond 755-nm alexandrite laser for treatment of dermal pigmentation in Asians-a retrospective study. Lasers Med Sci. 2020;35(6):1377–1383. doi:10.1007/s10103-020-02959-7
- Huang CH, Chern E, Peng JH, et al. Noninvasive atrophic acne scar treatment in Asians with a 755-nm picosecond laser using a diffractive optic lens-a retrospective photographic review. Dermatol Surg. 2019;45(2):195–202. doi:10.1097/DSS.0000000000001669
- Wat H, Shek SYN, Yeung CK, et al. Efficacy and safety of picosecond 755-nm alexandrite laser with diffractive lens array for non-ablative rejuvenation in Chinese skin. Lasers Surg Med. 2019;51(1):8–13. doi:10.1002/lsm.23014
- Tanghetti EA. The histology of skin treated with a picosecond alexandrite laser and a fractional lens array. Lasers Surg Med. 2016;48(7):646–652. doi:10.1002/lsm.22540
- McDaniel D. Gene expression analysis in cultured human skin fibroblasts following exposure to a picosecond pulsed alexandrite laser and specially designed focus optic. Lasers Surg Med. 2015;47(S26):22.
- Sasaki K, Ohshiro T, Ohshiro T, et al. Type 2 Minocycline-induced hyperpigmentation successfully treated with the novel 755 nm picosecond alexandrite laser-A case report. Laser Ther. 2017;26(2):137–144. doi:10.5978/islsm.17-CR-03
- Rivers JK, Zarbafian M, Vestvik B, et al. Minocycline-induced hyperpigmentation: rapid resolution after 755nm alexandrite picosecond laser treatment. J Cosmet Laser Ther. 2020;22(2):96–99. doi:10.1080/14764172.2020.1740275
- Barrett T, Zwaan SD. Picosecond alexandrite laser is superior to Q-switched Nd: YAGlaser in treatment of minocycline-induced hyperpigmentation: a case study and review of the literature. J Cosmet Laser Ther. 2018;20(7–8):387–390. doi:10.1080/14764172.2017.1418514
- Kok WL, Chua SH. Picosecond 755-nm alexandrite lasers are an effective treatment for imatinib-induced hyperpigmentation. Dermatol Surg. 2019;45(4):616–618. doi:10.1097/DSS.0000000000001868
- Lee YJ, Shin HJ, Noh TK, et al. Treatment of melasma and post-inflammatory hyperpigmentation by a picosecond 755-nm alexandrite laser in Asian patients. Ann Dermatol. 2017;29(6):779–781. doi:10.5021/ad.2017.29.6.779